Koers Alterity Therapeutics Limited Nasdaq
Aandelen
ATHE
US02155X2053
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,05 USD | -4,21% | -18,33% | -17,67% |
Omzet 2024 * | 1,87 mln. 1,74 mln. | Omzet 2025 * | 1,39 mln. 1,29 mln. | Marktkapitalisatie | 17,34 mln. 16,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,43 mln. | Nettowinst (verlies) 2025 * | -10 mln. -9,29 mln. | EV/omzet 2024 * | 9,29 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 12,5 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 86,93% |
Recentste transcriptie over Alterity Therapeutics Limited
1 dag | -4,21% | ||
1 week | -18,33% | ||
Lopende maand | -2,15% | ||
1 maand | +11,72% | ||
3 maanden | -1,44% | ||
6 maanden | -14,58% | ||
Lopend jaar | -17,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 01-05-17 |
Geoffrey Kempler
FOU | Founder | 69 | 11-11-97 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 01-05-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 11-11-97 |
Peter Marks
BRD | Director/Board Member | 68 | 29-07-05 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 08-08-11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
03-05-24 | 2,05 | -4,21% | 14 680 |
02-05-24 | 2,14 | -2,73% | 41 203 |
01-05-24 | 2,2 | +5,01% | 52 904 |
30-04-24 | 2,095 | -4,56% | 69 366 |
29-04-24 | 2,195 | -12,55% | 170 887 |
uitgestelde koers Nasdaq, 03 mei 2024 om 22:30 uur
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |